Reducing antipsychotic drug use in nursing homes. A controlled trial of provider education.

OBJECTIVE In the United States, 20% or more of nursing home residents receive antipsychotic drugs, primarily for the behavioral manifestations of dementia. This high level of use of drugs with substantial toxicity has engendered a strong and persistent controversy and recently has led to explicit regulatory measures to curtail use (Omnibus Budget Reconciliation Act of 1987). We developed and tested a comprehensive program to reduce antipsychotic use through education of physicians, nurses, and other nursing home staff. The primary elements of the program were instruction in use of behavioral techniques to manage behavior problems and encouragement of a trial of gradual antipsychotic withdrawal. DESIGN In a nonrandomized controlled trial, the program was implemented (beginning in August 1990) in two rural Tennessee community nursing homes with elevated antipsychotic use; two other comparable homes were selected as concurrent controls. PATIENTS Throughout the study 194 residents were in the education homes and 184 were in the control homes. Residents in both groups of homes had comparable demographic characteristics and functional status, and each group had a baseline rate of 29 days of antipsychotic use per 100 days of nursing home residence. MAIN OUTCOME MEASURES The primary end points were postintervention changes in administration of antipsychotics and other psychotropic drugs, use of physical restraints, and frequency of behavior problems. RESULTS Days of antipsychotic use decreased by 72% in the education homes vs 13% in the control homes (P < .001). No significant changes were noted in the use of other psychotropic drugs in either group. Days of physical restraint use decreased 36% in the education homes vs 5% in the control homes (P < .001). Behavior problem frequency did not increase in either group, even among the 48% of baseline antipsychotic users in the education homes who had antipsychotic drug regimens discontinued for 3 or more months. CONCLUSIONS The educational program led to a substantial reduction in antipsychotic use with no increase in the frequency of behavior problems. This suggests that for many antipsychotic drug users benefits may be marginal and that programs to reduce such drug use among the 250,000 US nursing home residents receiving these drugs should have high priority.

[1]  L. Melton,et al.  Psychotropic drug use and the risk of hip fracture. , 1987, The New England journal of medicine.

[2]  S. Baker,et al.  Medications and Diagnoses in Relation to Falls in a Long‐Term Care Facility , 1987, Journal of the American Geriatrics Society.

[3]  W. Schaffner,et al.  The risk of anticholinergic toxicity in the elderly: a study of prescribing practices in two populations. , 1983, Journal of gerontology.

[4]  P. Heacock,et al.  Nursing interventions for patients with Alzheimer's disease. , 1988, The Nursing clinics of North America.

[5]  Michael J. Lichtenstein,et al.  The Nursing Home Behavior Problem Scale. , 2018, Journal of gerontology.

[6]  E. Hing,et al.  Use of nursing homes by the elderly: preliminary data from the 1985 National Nursing Home Survey. , 1987, Advance data.

[7]  D. Riesenberg Drugs in the institutionalized elderly: time to get it right? , 1988, JAMA.

[8]  L. Schneider,et al.  A Metaanalysis of Controlled Trials of Neuroleptic Treatment in Dementia , 1990, Journal of the American Geriatrics Society.

[9]  S. Clauser,et al.  Managing behavior problems in nursing homes. , 1991, JAMA.

[10]  G. Honigfeld NOSIE--30: history and current status of its use in pharmacopsychiatric research. , 1974, Modern problems of pharmacopsychiatry.

[11]  L. G. Pawlson,et al.  OBRA 87 ‐ A Commentary , 1991, Journal of the American Geriatrics Society.

[12]  W. Schaffner,et al.  A study of antipsychotic drug use in nursing homes: epidemiologic evidence suggesting misuse. , 1980, American journal of public health.

[13]  B. Burns,et al.  Psychotropic drug prescriptions for nursing home residents. , 1988, The Journal of family practice.

[14]  W A Ray,et al.  Use of Medicaid data for pharmacoepidemiology. , 1989, American journal of epidemiology.

[15]  B. Mcfarland,et al.  Tardive dyskinesia in the aged. Duration of treatment relationships. , 1985, Archives of general psychiatry.

[16]  W. Schaffner,et al.  Improving antibiotic prescribing in office practice. A controlled trial of three educational methods. , 1983, JAMA.

[17]  B. Svarstad,et al.  Nursing Home Resources and Tranquilizer Use among the Institutionalized Elderly , 1991, Journal of the American Geriatrics Society.

[18]  Stephen B. Soumerai,et al.  Improving Drug-Therapy Decisions through Educational Outreach , 1983 .

[19]  J. Cohen-Mansfield Agitated Behaviors in the Elderly: II. Preliminary Results in the Cognitively Deteriorated , 1986, Journal of the American Geriatrics Society.

[20]  Paul M. Helms Efficacy of Antipsychotics in the Treatment of the Behavioral Complications of Dementia: A Review of the Literature , 1985, Journal of the American Geriatrics Society.

[21]  R. Kane,et al.  Evaluation of neuroleptic drug use by nursing home elderly under proposed Medicare and Medicaid regulations. , 1991, JAMA.

[22]  M. Kendall,et al.  The advanced theory of statistics , 1945 .

[23]  B. O’Donnell,et al.  Troublesome and Disruptive Behaviors in Dementia , 1988, Journal of the American Geriatrics Society.

[24]  N. Watson,et al.  Behavioral problems among patients in skilled nursing facilities. , 1984, American journal of public health.

[25]  J. Rader A comprehensive staff approach to problem wandering. , 1987, The Gerontologist.

[26]  J. Avorn,et al.  Psychoactive medication use in intermediate-care facility residents. , 1988, JAMA.

[27]  K. Solomon,et al.  The Use of Mechanical and Chemical Restraints in Nursing Homes , 1977, Journal of the American Geriatrics Society.

[28]  J. Avorn,et al.  Improving Medication Prescribing and Utilization in the Nursing Home , 1990, Journal of the American Geriatrics Society.

[29]  B. Burns,et al.  Prescribing of Psychotropics in Elderly Nursing Home Patients , 1989, Journal of the American Geriatrics Society.

[30]  C. Fairburn,et al.  Changes in Behaviour in Dementia: A Neglected Research Area , 1988, British Journal of Psychiatry.

[31]  W. Schaffner,et al.  Reducing antipsychotic drug prescribing for nursing home patients: a controlled trial of the effect of an educational visit. , 1987, American journal of public health.

[32]  S R Salem-Schatz,et al.  A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. , 1992, The New England journal of medicine.

[33]  W. Snow,et al.  On the Clinical Value of the London Psychogeriatric Rating Scale , 1991, Journal of the American Geriatrics Society.

[34]  P. Sloane,et al.  Physical and pharmacologic restraint of nursing home patients with dementia. Impact of specialized units. , 1991, JAMA.

[35]  J. Morris,et al.  The Progression of Personality Changes in Senile Dementia of the Alzheimer's Type , 1987, Journal of the American Geriatrics Society.

[36]  R. Barnes,et al.  Pharmacologic Treatment of Agitation Associated With Dementia , 1986, Journal of the American Geriatrics Society.

[37]  M. Tinetti,et al.  Fall risk index for elderly patients based on number of chronic disabilities. , 1986, The American journal of medicine.